New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 15, 2014
11:09 EDTSYKStryker sees FY13 adjusted EPS $4.20-$4.26, consensus $4.23
Sees FY adjusted EPS growth 10%-12%. Sees FY13 organic sales growth 4.5%-5.5%, consensus $8.99B. Capital allocation plans include: M&A to drive growth, dividend growth, share repurchases. Sees 15% increase in dividend for 2014. Comments from slides that are being presented at the JP Morgan Healthcare Conference.
News For SYK From The Last 14 Days
Check below for free stories on SYK the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 24, 2014
08:19 EDTSYKLeerink medical devices analyst holds an analyst/industry conference call
Subscribe for More Information
July 23, 2014
13:36 EDTSYKIntuitive Surgical rises after Q2 EPS, revenue beat expectations
Subscribe for More Information
July 22, 2014
08:36 EDTSYKStryker appoints CEO Kevin Lobo as chairman
Subscribe for More Information
July 18, 2014
09:00 EDTSYKStryker price target raised to $92 from $87 at RW Baird
Baird raised its price target on Stryker to $92 from $87 citing valuation, organic sales growth, and solid risk/reward. The firm has an Outperform rating on the stock.
July 17, 2014
16:09 EDTSYKStryker sees Q3 adjusted EPS $1.12-$1.16 , consensus $1.16
"If foreign currency exchange rates hold near current levels, we do not expect the impact on third quarter or full year net sales to be significant," the company said.
16:08 EDTSYKStryker sees FY14 adjusted EPS $4.75-$4.80, consensus $4.80
Now projecting full year organic sales growth to be in the range of 5.0%-6.0%, consensus $9.61B.
16:07 EDTSYKStryker reports Q2 adjusted EPS $1.08, consensus $1.08
Subscribe for More Information
15:26 EDTSYKNotable companies reporting after market close
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use